Sarcoma, Alveolar Soft Part
"Sarcoma, Alveolar Soft Part" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A variety of rare sarcoma having a reticulated fibrous stroma enclosing groups of sarcoma cells, which resemble epithelial cells and are enclosed in alveoli walled with connective tissue. It is a rare tumor, usually occurring between 15 and 35 years of age. It appears in the muscles of the extremities in adults and most commonly in the head and neck regions of children. Though slow-growing, it commonly metastasizes to the lungs, brain, bones, and lymph nodes. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1365)
MeSH Number(s)
C04.557.450.590.775
C04.557.450.795.775
Below are MeSH descriptors whose meaning is more general than "Sarcoma, Alveolar Soft Part".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma, Alveolar Soft Part".
This graph shows the total number of publications written about "Sarcoma, Alveolar Soft Part" by people in Harvard Catalyst Profiles by year, and whether "Sarcoma, Alveolar Soft Part" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Sarcoma, Alveolar Soft Part" by people in Profiles.
-
PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia. Am J Surg Pathol. 2022 08 01; 46(8):1153-1159.
-
Human Cytomegalovirus is Present in Alveolar Soft Part Sarcoma. Appl Immunohistochem Mol Morphol. 2017 Oct; 25(9):615-619.
-
Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma. PLoS One. 2017; 12(9):e0185321.
-
Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics. Am J Surg Pathol. 2017 May; 41(5):622-632.
-
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. Cancer. 2017 Jan 01; 123(1):90-97.
-
Prognostic factors in alveolar soft part sarcoma: A SEER analysis. J Surg Oncol. 2016 Apr; 113(5):581-6.
-
Granular cell tumors overexpress TFE3 without corollary gene rearrangement--Reply. Hum Pathol. 2015 Aug; 46(8):1243.
-
Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines. Clin Cancer Res. 2015 Jul 15; 21(14):3178-86.
-
Extended progression-free survival in two patients with alveolar soft part sarcoma exposed to tivantinib. J Clin Oncol. 2014 Dec 01; 32(34):e114-6.
-
Imaging features of primary and metastatic alveolar soft part sarcoma: single institute experience in 25 patients. Br J Radiol. 2014 Apr; 87(1036):20130719.